4SC AG
Biopharmaceutical company with no products under development or operational business.
VSC | F
Overview
Corporate Details
- ISIN(s):
- DE000A3E5C40
- LEI:
- 391200QOKN7LGVP0RQ86
- Country:
- Germany
- Address:
- Fraunhoferstr. 22, 82152 Planegg
- Website:
- https://www.4sc.com/
- Sector:
- Manufacturing
Description
4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2015-01-14 00:00 |
Datum:14.01.2015
|
German | HTML • 11.9 KB | ||
| 2015-01-13 07:30 |
Press Release 4SC AG: BEYOND RESEARCH initiative of 4SC Discovery and CRELUX re…
|
English | HTML • 19.2 KB | ||
| 2015-01-12 07:30 |
Press Release 4SC AG: Prof. Dr. Helga Rubsamen-Schaeff and Joerg von Petrikowsk…
|
English | HTML • 9.0 KB | ||
| 2014-12-09 07:30 |
Press Release: 4SC reports positive topline data from clinical Phase I trial wi…
|
English | HTML • 15.0 KB | ||
| 2014-11-28 14:08 |
Release according to Article 26a of the WpHG [the German Securities Trading Act…
|
English | HTML • 1.6 KB | ||
| 2014-11-07 00:00 |
Q3 Report 2014
|
English | PDF • 3.4 MB | ||
| 2014-11-06 07:30 |
Press Release: 4SC announces financial results for the first nine months and th…
|
English | HTML • 22.0 KB | ||
| 2014-10-30 15:00 |
Announcement: 4SC to host conference call on 6 November 2014 to present third q…
|
English | HTML • 7.4 KB | ||
| 2014-10-21 07:30 |
Press Release: 4SC further strengthens patent protection for its lead compound …
|
English | HTML • 11.9 KB | ||
| 2014-10-07 07:30 |
Press Release: 4SC's partner Yakult Honsha completes Phase I part of clinical s…
|
English | HTML • 14.7 KB | ||
| 2014-09-23 07:30 |
Press Release: 4SC's partner Yakult Honsha completes Phase I part of clinical s…
|
English | HTML • 14.2 KB | ||
| 2014-09-03 15:07 |
4SC AG issues second tranche of convertible notes with a nominal amount of EUR …
|
English | HTML • 5.3 KB | ||
| 2014-08-18 17:54 |
4SC AG: Dr Thomas Werner and Klaus Kuhn announce resignation from Supervisory B…
|
English | HTML • 5.1 KB | ||
| 2014-08-08 00:00 |
Q2 Report 2014
|
English | PDF • 3.5 MB | ||
| 2014-08-07 07:30 |
Press Release: 4SC Announces Financial Results for the First Half of 2014
|
English | HTML • 23.0 KB |
Automate Your Workflow. Get a real-time feed of all 4SC AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for 4SC AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for 4SC AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
